These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2430769)

  • 1. [Strategies in the therapy of hepatitis B surface antigen (HBsAg-)-positive chronic hepatitis].
    Hess G; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1933-7. PubMed ID: 2430769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment problems in chronic hepatitis].
    Chernev K
    Vutr Boles; 1982; 21(1):6-12. PubMed ID: 6178223
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic hepatitis B].
    Jilg W
    Dtsch Med Wochenschr; 1989 Aug; 114(31-32):1224. PubMed ID: 2752927
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dynamics examination of eliminating surface antigen of Hepatitis B Virus (HBsAg) and its significance for the prognosis of the disease and the carrier state (author's transl)].
    Pejcochová J; Jandásek L; Jezek P; Horecká J
    Cesk Epidemiol Mikrobiol Imunol; 1978 Apr; 27(2):79-83. PubMed ID: 149606
    [No Abstract]   [Full Text] [Related]  

  • 5. The hepatitis B carrier state.
    Murray BJ
    Am Fam Physician; 1986 Apr; 33(4):127-33. PubMed ID: 2938461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of hepatitis B surface antigen (HBsAg) in patients with pulmonary tuberculosis].
    Fondaminskaia LD
    Probl Tuberk; 1986; (3):25-7. PubMed ID: 3714688
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and management of chronic active hepatitis.
    Hazzi C
    Am J Gastroenterol; 1986 Jan; 81(1):85-90. PubMed ID: 3942127
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiviral treatment of chronic hepatitis B].
    Bourel M; Brissot P
    Rev Prat; 1987 Apr; 37(23):1353-7. PubMed ID: 2440096
    [No Abstract]   [Full Text] [Related]  

  • 9. The need and value of routine screening of all pregnant women for hepatitis B surface antigen.
    Capar M; Kosić-Andrasević V; Popić G; Raguz L; Mahuĺja-Stamenković V; Zuzek A; Dujmović A; Milevoj-Razem M; Ljutić S
    Acta Med Croatica; 1995; 49(4-5):161-4. PubMed ID: 8630446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapy in HBsAg-positive chronic liver disease (HBsAg+ve CLD): how many patients really need it?
    Ascione A; Amitrano L; Riccio E; De Lella A; Canestrini C; de Bellis G; D'Alessandro R; Fiore R; Padulano P
    Hepatogastroenterology; 1984 Jun; 31(3):123-4. PubMed ID: 6469200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies of the so-called asymptomatic carriers of surface antigen HBsAg of hepatitis B virus].
    Urbański S; Kowalewski R
    Wiad Lek; 1979 Feb; 32(3):141-4. PubMed ID: 442638
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiviral therapy of HBsAg positive chronic hepatitis: progress or erroneous development?].
    Hess G
    Med Klin (Munich); 1987 May; 82(11):419-20. PubMed ID: 3600545
    [No Abstract]   [Full Text] [Related]  

  • 13. [Echohepatographic data on chronic HBs-antigen carriers].
    Postovit NV
    Vrach Delo; 1982 Apr; (4):109-11. PubMed ID: 7101843
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of hepatitis B e antigen in pregnant women and patients with liver disease.
    Gill HH; Majumdar PD; Dhunjibhoy KR; Desai HG
    J Assoc Physicians India; 1995 Apr; 43(4):247-8. PubMed ID: 8713262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of HBsAg positive hepatopathy.
    Seidlová V
    Acta Univ Palacki Olomuc Fac Med; 1985; 111():287-98. PubMed ID: 2949508
    [No Abstract]   [Full Text] [Related]  

  • 16. The diagnosis and management of acute viral hepatitis.
    Bolin TD; Duncombe VM
    Aust Fam Physician; 1977 Dec; 6(12):1611-4. PubMed ID: 603455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis and characteristics of the course of HBsAg-positive and HBsAg-negative chronic persistent hepatitis].
    Dzhumabaev TZ
    Klin Med (Mosk); 1989 Feb; 67(2):73-5. PubMed ID: 2724893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis and treatment of hepatitis B in immunocompromised patients.
    Marzano A; Angelucci E; Andreone P; Brunetto M; Bruno R; Burra P; Caraceni P; Daniele B; Di Marco V; Fabrizi F; Fagiuoli S; Grossi P; Lampertico P; Meliconi R; Mangia A; Puoti M; Raimondo G; Smedile A;
    Dig Liver Dis; 2007 May; 39(5):397-408. PubMed ID: 17382608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects and diagnosis of chronic viral hepatitis B].
    Grigor'ev PIa; Iakovenko EP; Zakharov VN; Saiapina ES; Shubina GI
    Klin Med (Mosk); 1984 Feb; 62(2):5-10. PubMed ID: 6708442
    [No Abstract]   [Full Text] [Related]  

  • 20. Research on a new hepatitis B antigen-antibody system: e-anti-e.
    Ortona L; Pizzigallo E; Federico G; Camilli G; Scian J
    Boll Ist Sieroter Milan; 1977 Nov; 56(5):467-75. PubMed ID: 597398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.